Showing 1 to 12 of 30 results


Lithium Shows Promise in Alzheimer's Prevention and Treatment
A Harvard-led study reveals that lithium, previously used to treat mood disorders, shows potential in preventing and treating Alzheimer's disease by reducing amyloid protein buildup and improving cognitive function in mice.
Lithium Shows Promise in Alzheimer's Prevention and Treatment
A Harvard-led study reveals that lithium, previously used to treat mood disorders, shows potential in preventing and treating Alzheimer's disease by reducing amyloid protein buildup and improving cognitive function in mice.
Progress
16% Bias Score


Brain Lithium Depletion Linked to Alzheimer's Disease Progression: Mouse Study Shows Promise
A Harvard University study published in Nature found lower brain lithium levels in individuals with Alzheimer's disease and mild cognitive impairment compared to healthy controls; low-dose lithium orotate supplementation protected against Alzheimer's-related damage in mice, suggesting potential prev...
Brain Lithium Depletion Linked to Alzheimer's Disease Progression: Mouse Study Shows Promise
A Harvard University study published in Nature found lower brain lithium levels in individuals with Alzheimer's disease and mild cognitive impairment compared to healthy controls; low-dose lithium orotate supplementation protected against Alzheimer's-related damage in mice, suggesting potential prev...
Progress
52% Bias Score


Weekly Parkinson's Injection Shows Promise
Australian researchers created a weekly injection for Parkinson's, combining Levodopa and Carbidopa, to improve adherence and reduce the risk of falls among the over 10 million people globally affected by the disease; animal testing is planned.
Weekly Parkinson's Injection Shows Promise
Australian researchers created a weekly injection for Parkinson's, combining Levodopa and Carbidopa, to improve adherence and reduce the risk of falls among the over 10 million people globally affected by the disease; animal testing is planned.
Progress
52% Bias Score


Dogs Accurately Detect Parkinson's Disease from Scent
A study found that two dogs, a Golden Retriever and a Labrador-Golden Retriever mix, accurately identified 70-80% of Parkinson's disease patients from sebum samples, with even higher accuracy in identifying healthy individuals (90-98%).
Dogs Accurately Detect Parkinson's Disease from Scent
A study found that two dogs, a Golden Retriever and a Labrador-Golden Retriever mix, accurately identified 70-80% of Parkinson's disease patients from sebum samples, with even higher accuracy in identifying healthy individuals (90-98%).
Progress
44% Bias Score


Sensory Changes: Early Warning Signs of Dementia
Experts warn that changes in sight, hearing, taste, touch, and balance can be early signs of dementia, striking years before memory problems, offering hope for earlier diagnosis and intervention; studies show sensory changes are often overlooked, highlighting the need for their inclusion in standard...
Sensory Changes: Early Warning Signs of Dementia
Experts warn that changes in sight, hearing, taste, touch, and balance can be early signs of dementia, striking years before memory problems, offering hope for earlier diagnosis and intervention; studies show sensory changes are often overlooked, highlighting the need for their inclusion in standard...
Progress
36% Bias Score


ALS: Symptoms, Causes, and Emerging Treatments
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting motor neurons, causing muscle weakness, speech/swallowing difficulties, and eventually paralysis; it affects 1–3 per 100,000 globally, with Riluzole offering some treatment, while research focuses on immunotherapies.
ALS: Symptoms, Causes, and Emerging Treatments
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting motor neurons, causing muscle weakness, speech/swallowing difficulties, and eventually paralysis; it affects 1–3 per 100,000 globally, with Riluzole offering some treatment, while research focuses on immunotherapies.
Progress
16% Bias Score

IGF-II Shows Neuroprotective Effects in Parkinson's Disease
Researchers at IBIMA and the University of Málaga found that the hormone IGF-II protects nerve cells from Parkinson's damage, offering a potential new treatment to slow disease progression, as published in the Journal of Advanced Research.

IGF-II Shows Neuroprotective Effects in Parkinson's Disease
Researchers at IBIMA and the University of Málaga found that the hormone IGF-II protects nerve cells from Parkinson's damage, offering a potential new treatment to slow disease progression, as published in the Journal of Advanced Research.
Progress
24% Bias Score

Weekly Parkinson's Injection Offers Hope for Millions
Australian scientists created a weekly injection combining Levodopa and Carbidopa to treat Parkinson's disease, improving adherence for the 10 million+ sufferers globally, with men affected 1.5 times more often than women.

Weekly Parkinson's Injection Offers Hope for Millions
Australian scientists created a weekly injection combining Levodopa and Carbidopa to treat Parkinson's disease, improving adherence for the 10 million+ sufferers globally, with men affected 1.5 times more often than women.
Progress
52% Bias Score

Dogs Accurately Detect Parkinson's Disease Using Sebum Samples
In a study, two dogs accurately identified Parkinson's patients (70-80%) using sebum samples; this non-invasive method could improve early diagnosis, complementing existing approaches.

Dogs Accurately Detect Parkinson's Disease Using Sebum Samples
In a study, two dogs accurately identified Parkinson's patients (70-80%) using sebum samples; this non-invasive method could improve early diagnosis, complementing existing approaches.
Progress
44% Bias Score

Tetraneuron's Novel Gene Therapy Targets Alzheimer's Disease by Restoring Neuronal Function
Tetraneuron, based on research from the Cajal Institute in Madrid, is developing a gene therapy for moderate-to-severe Alzheimer's disease by targeting the transcription factor E2F4, showing promising results in animal models and aiming for human trials in 2026.

Tetraneuron's Novel Gene Therapy Targets Alzheimer's Disease by Restoring Neuronal Function
Tetraneuron, based on research from the Cajal Institute in Madrid, is developing a gene therapy for moderate-to-severe Alzheimer's disease by targeting the transcription factor E2F4, showing promising results in animal models and aiming for human trials in 2026.
Progress
32% Bias Score

Gut Microbiome Imbalance Linked to Increased Parkinson's Risk
A King's College London study found that people with Parkinson's disease have a less diverse gut microbiome and higher levels of harmful bacteria than healthy controls, suggesting that a diet low in ultra-processed foods could reduce the risk of developing Parkinson's.

Gut Microbiome Imbalance Linked to Increased Parkinson's Risk
A King's College London study found that people with Parkinson's disease have a less diverse gut microbiome and higher levels of harmful bacteria than healthy controls, suggesting that a diet low in ultra-processed foods could reduce the risk of developing Parkinson's.
Progress
24% Bias Score

High Ultra-Processed Food Intake Linked to Increased Parkinson's Disease Risk
A study of nearly 43,000 participants found that consuming 11 or more servings of ultra-processed foods daily is associated with a 2.5 times greater likelihood of experiencing multiple early-stage Parkinson's symptoms compared to those eating only three servings; the findings suggest potential preve...

High Ultra-Processed Food Intake Linked to Increased Parkinson's Disease Risk
A study of nearly 43,000 participants found that consuming 11 or more servings of ultra-processed foods daily is associated with a 2.5 times greater likelihood of experiencing multiple early-stage Parkinson's symptoms compared to those eating only three servings; the findings suggest potential preve...
Progress
36% Bias Score
Showing 1 to 12 of 30 results